Market Overview:
The global dermatological therapeutics market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of skin diseases, rising awareness about available treatments, and growing demand for minimally invasive procedures. The global dermatological therapeutics market is segmented by type into anti-infectives, corticosteroids, anti psoriasis, anti-acne and others. The corticosteroids segment is expected to grow at the highest CAGR during the forecast period owing to its high usage in various skin diseases such as eczema and psoriasis. By application, the global dermatological therapeutics market is segmented into hospital and clinic settings. The hospital setting segment is expected to grow at a higher CAGR during the forecast period owing to increasing use of novel therapies in this setting coupled with rising prevalence of skin diseases.
Product Definition:
Dermatological Therapeutics is the branch of medicine that deals with the diagnosis and treatment of conditions affecting the skin, hair, and nails. The importance of dermatological therapeutics is that it allows for the treatment of a wide variety of conditions that can affect a person's appearance and quality of life.
Anti-infectives:
Anti-infectives is a branch of pharmacology that deals with the study of anti-microbial drugs and their use against infectious diseases. The global market for anti-infectives is expected to witness significant growth over the forecast period owing to increasing prevalence rate of chronic diseases such as HIV, cancer, diabetes mellitus and other autoimmune disorders coupled with rising geriatric population base globally.
Corticosteroids:
Corticosteroids are the group of drugs that act as anti-inflammatory agents and immunosuppressants. They are synthetically produced or derived from natural sources such as cholesterol. Corticosteroid hormones have two distinctive forms, namely adrenal and oral steroids.
Application Insights:
The hospital application segment dominated the global dermal therapeutics market in 2017. The growing prevalence of chronic diseases, especially skin disorders and injuries is expected to drive the demand for dermatological therapeutics at hospitals. According to a study published by NCBI, it was observed that around 60% of patients visiting primary healthcare centers are diagnosed with skin diseases. In addition, according to WHO, around 50 million people annually suffer from burns due to accidents or violence which requires treatment in a hospital setting globally. This factor is anticipated to fuel segment growth during the forecast period.
Clinic applications accounted for 29% share of total revenue in 2017 owing to increasing awareness about available treatments and new products being launched by prominent players such as Galderma Laboratories received FDA approval for its anti-aging product line which includes ¢â‚¬Å“Renewal Program¢â‚¬.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of skin disorders, rising awareness about early diagnosis and availability of effective treatment options. Moreover, high adoption of cosmetic products that contain active ingredients derived from plants is also driving growth in this region.
Asia Pacific is estimated to be the fastest-growing regional market during the forecast period owing to a rise in disposable income levels and growing medical tourism industry especially for dermatology treatments & procedures. In addition, an increase in per capita income levels will also help boost demand for anti-infectives as well as other dermatoic medicines over this coming years. Furthermore, government initiatives are being undertaken by various countries such as India and China aimed at creating awareness among people regarding early diagnosis & treatment options for skin diseases are anticipated to further fuel growth over the next eight years (2030).
Growth Factors:
- Increasing incidence of skin diseases: The global dermatological therapeutics market is expected to grow at a CAGR of 5.5% from 2016 to 2021, owing to the increasing incidence of skin diseases such as psoriasis, acne vulgaris, and eczema.
- Rising awareness about skin care: There is an increasing awareness among people about the importance of taking care of their skin and using appropriate skincare products. This is driving the demand for dermatological therapeutics products worldwide.
- Growing demand for cosmeceuticals: The use of cosmeceuticals (cosmetic products that have medicinal properties) is growing rapidly due to their efficacy in treating various skin problems such as wrinkles, age spots, and sun damage etc. This is contributing significantly to the growth of the global dermatological therapeutics market.
- Valeant Pharmaceuticals International Inc., launched two new drugs – Jublia (efinaconazole) 10% topical solution and Solodyn (minocycline HCl extended-release tablets) – for treating onychomycosis (a fungal infection affecting nails) and moderate-to-severe acne respectively .This will help boost growth prospects for the global dermatological therapeutics market in coming years . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Dermatological Therapeutics Market Research Report
By Type
Anti-infectives, Corticosteroids, Anti Psoriasis, Anti-acne, Others
By Application
Hospital, Clinic
By Companies
AGI Dermatics, Allergan, Amgen, Chester Valley, Dermik, Eisai, Ferndale, Genentech, Medicis, Onset Therapeutics, AGI Dermatics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
170
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Dermatological Therapeutics Market Report Segments:
The global Dermatological Therapeutics market is segmented on the basis of:
Types
Anti-infectives, Corticosteroids, Anti Psoriasis, Anti-acne, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AGI Dermatics
- Allergan
- Amgen
- Chester Valley
- Dermik
- Eisai
- Ferndale
- Genentech
- Medicis
- Onset Therapeutics
- AGI Dermatics
Highlights of The Dermatological Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anti-infectives
- Corticosteroids
- Anti Psoriasis
- Anti-acne
- Others
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dermatological Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dermatological therapies are treatments that focus on the skin. These treatments can be used to treat a variety of conditions, including skin cancer, psoriasis, and other types of dermatitis.
Some of the major players in the dermatological therapeutics market are AGI Dermatics, Allergan, Amgen, Chester Valley, Dermik, Eisai, Ferndale, Genentech, Medicis, Onset Therapeutics, AGI Dermatics.
The dermatological therapeutics market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dermatological Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dermatological Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dermatological Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dermatological Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dermatological Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Dermatological Therapeutics Market Size and Y-o-Y Growth
4.5.2 Dermatological Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Dermatological Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Dermatological Therapeutics Market Size Forecast by Type
5.2.1 Anti-infectives
5.2.2 Corticosteroids
5.2.3 Anti Psoriasis
5.2.4 Anti-acne
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Dermatological Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Dermatological Therapeutics Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dermatological Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dermatological Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Dermatological Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Dermatological Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Dermatological Therapeutics Market Size Forecast by Type
9.6.1 Anti-infectives
9.6.2 Corticosteroids
9.6.3 Anti Psoriasis
9.6.4 Anti-acne
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Dermatological Therapeutics Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Dermatological Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Dermatological Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Dermatological Therapeutics Market Size Forecast by Type
10.6.1 Anti-infectives
10.6.2 Corticosteroids
10.6.3 Anti Psoriasis
10.6.4 Anti-acne
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Dermatological Therapeutics Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Dermatological Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Dermatological Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Dermatological Therapeutics Market Size Forecast by Type
11.6.1 Anti-infectives
11.6.2 Corticosteroids
11.6.3 Anti Psoriasis
11.6.4 Anti-acne
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Dermatological Therapeutics Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Dermatological Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Dermatological Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Dermatological Therapeutics Market Size Forecast by Type
12.6.1 Anti-infectives
12.6.2 Corticosteroids
12.6.3 Anti Psoriasis
12.6.4 Anti-acne
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Dermatological Therapeutics Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Dermatological Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Dermatological Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Dermatological Therapeutics Market Size Forecast by Type
13.6.1 Anti-infectives
13.6.2 Corticosteroids
13.6.3 Anti Psoriasis
13.6.4 Anti-acne
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Dermatological Therapeutics Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dermatological Therapeutics Market: Competitive Dashboard
14.2 Global Dermatological Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AGI Dermatics
14.3.2 Allergan
14.3.3 Amgen
14.3.4 Chester Valley
14.3.5 Dermik
14.3.6 Eisai
14.3.7 Ferndale
14.3.8 Genentech
14.3.9 Medicis
14.3.10 Onset Therapeutics
14.3.11 AGI Dermatics
